{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:38:32Z","timestamp":1786981112016,"version":"build-2736575974"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T00:00:00Z","timestamp":1692921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["TO2022\/3"],"award-info":[{"award-number":["TO2022\/3"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004477","name":"Stellenbosch University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Up to 50% of systemic lupus erythematosus (SLE) patients world-wide develop lupus nephritis (LN). In low to middle income countries and in particular in sub-Saharan Africa, where SLE is prevalent with a more aggressive course, LN and end stage renal disease is a major cause of mortality. While developed countries have the funding to invest in SLE and LN research, patients of African descent are often underrepresented in clinical trials. Thus, the complex influence of ethnicity and genetic background on outcome of LN and SLE as a whole, is not fully understood. Several pathophysiological mechanisms including major role players driving LN have been identified. A large body of literature suggest that prevention of fibrosis\u2014which contributes to chronicity of LN\u2014may significantly improve long-term prognosis. Bone morphogenetic protein-7 (BMP-7) was first identified as a therapeutic option in this context decades ago and evidence of its benefit in various conditions, including LN, is ever-increasing. Despite these facts, BMP-7 is not being implemented as therapy in the context of renal disease. With this review, we briefly summarise current understanding of LN pathology and discuss the evidence in support of therapeutic potential of BMP-7 in this context. Lastly, we address the obstacles that need to be overcome, before BMP-7 may become available as LN treatment.<\/jats:p>","DOI":"10.1007\/s10787-023-01321-x","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T14:02:25Z","timestamp":1692972145000},"page":"2161-2172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-9204","authenticated-orcid":false,"given":"Carine","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riette","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Ollewagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,25]]},"reference":[{"issue":"1","key":"1321_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/acr.24892","volume":"75","author":"A Aguirre","year":"2023","unstructured":"Aguirre A et al (2023) Race, ethnicity, and disparities in the risk of end-organ lupus manifestations following a systemic lupus erythematosus diagnosis in a multiethnic cohort. Arthritis Care Res 75(1):34\u201343. https:\/\/doi.org\/10.1002\/acr.24892","journal-title":"Arthritis Care Res"},{"key":"1321_CR2","unstructured":"AI in clinical trials market (2023) MarketsandMarkets Research Private Ltd. https:\/\/www.marketsandmarkets.com\/Market-Reports\/ai-in-clinical-trials-market-42687548.html. Accessed 17 May 2023"},{"issue":"4","key":"1321_CR3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/sj.bjc.6606075","volume":"104","author":"M Aoki","year":"2011","unstructured":"Aoki M et al (2011) Expression of BMP-7 in human gastric cancer and its clinical significance. Br J Cancer 104(4):714\u2013718. https:\/\/doi.org\/10.1038\/sj.bjc.6606075","journal-title":"Br J Cancer"},{"issue":"7","key":"1321_CR4","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi A et al (2019) The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol 20(7):902\u2013914. https:\/\/doi.org\/10.1038\/s41590-019-0398-x","journal-title":"Nat Immunol"},{"issue":"1","key":"1321_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2165\/00024677-200403010-00003","volume":"3","author":"AD Askanase","year":"2004","unstructured":"Askanase AD (2004) Estrogen therapy in systemic lupus erythematosus. Treat Endocrinol 3(1):19\u201326. https:\/\/doi.org\/10.2165\/00024677-200403010-00003","journal-title":"Treat Endocrinol"},{"key":"1321_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12553-023-00738-2","volume":"13","author":"S Askin","year":"2023","unstructured":"Askin S et al (2023) Artificial intelligence applied to clinical trials: opportunities and challenges. Health Technol 13:203\u2013213. https:\/\/doi.org\/10.1007\/s12553-023-00738-2","journal-title":"Health Technol"},{"issue":"12","key":"1321_CR7","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/acr.23550.Intramuscular","volume":"70","author":"JF Baker","year":"2018","unstructured":"Baker JF et al (2018) Intramuscular fat accumulation and associations with body composition, strength and physical functioning in rheumatoid arthritis. Arthritis Care Res (Hoboken) 70(12):1727\u20131734. https:\/\/doi.org\/10.1002\/acr.23550.Intramuscular","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"1321_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","volume":"17","author":"MRW Barber","year":"2021","unstructured":"Barber MRW et al (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17(9):515\u2013532. https:\/\/doi.org\/10.1038\/s41584-021-00668-1","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"1321_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0177188","volume":"12","author":"LK Bollum","year":"2017","unstructured":"Bollum LK et al (2017) BMP-7 induces apoptosis in human germinal center B cells and. PLoS\u00a0One 12(5):1\u201318. https:\/\/doi.org\/10.1371\/journal.pone.0177188","journal-title":"PLoS\u00a0One"},{"issue":"11","key":"1321_CR10","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1177\/0961203317693097","volume":"26","author":"U Brijlal","year":"2017","unstructured":"Brijlal U, Bates WD, Moosa MR (2017) Lupus nephritis in the Western Cape, a high prevalence area: an experience over three decades. Lupus 26(11):1228\u20131234. https:\/\/doi.org\/10.1177\/0961203317693097","journal-title":"Lupus"},{"issue":"2","key":"1321_CR11","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.20171508","volume":"215","author":"T Capucha","year":"2018","unstructured":"Capucha T et al (2018) Sequential BMP7\/TGF-\u03b21 signaling and microbiota instruct mucosal Langerhans cell differentiation. J Exp Med 215(2):481\u2013500. https:\/\/doi.org\/10.1084\/jem.20171508","journal-title":"J Exp Med"},{"issue":"July","key":"1321_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.864509","volume":"13","author":"WD Carlson","year":"2022","unstructured":"Carlson WD et al (2022) A process for the design and development of novel bone morphogenetic protein-7 (BMP-7) mimetics with an example: THR-184. Front Pharmacol 13(July):1\u201318. https:\/\/doi.org\/10.3389\/fphar.2022.864509","journal-title":"Front Pharmacol"},{"issue":"8","key":"1321_CR13","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1038\/ki.2008.209","volume":"74","author":"WL Chan","year":"2008","unstructured":"Chan WL et al (2008) BMP-7 protects mesangial cells from injury by polymeric IgA. Kidney Int 74(8):1026\u20131039. https:\/\/doi.org\/10.1038\/ki.2008.209","journal-title":"Kidney Int"},{"issue":"3","key":"1321_CR14","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.4049\/jimmunol.1001983.In","volume":"186","author":"A Chang","year":"2011","unstructured":"Chang A et al (2011) In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis. Bone 186(3):1849\u20131860. https:\/\/doi.org\/10.4049\/jimmunol.1001983.In","journal-title":"Bone"},{"issue":"2","key":"1321_CR15","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/BOR.0000000000000777","volume":"33","author":"A Chang","year":"2021","unstructured":"Chang A, Clark MR, Ko K (2021) Cellular aspects of the pathogenesis of lupus nephritis. Curr Opin Rheumatol 33(2):197\u2013204. https:\/\/doi.org\/10.1097\/BOR.0000000000000777","journal-title":"Curr Opin Rheumatol"},{"issue":"10","key":"1321_CR16","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/apm.12730","volume":"125","author":"F Chen","year":"2017","unstructured":"Chen F et al (2017) BMP-7 ameliorates cobalt alloy particle-induced inflammation by suppressing Th17 responses. Apmis 125(10):880\u2013887. https:\/\/doi.org\/10.1111\/apm.12730","journal-title":"Apmis"},{"issue":"1","key":"1321_CR17","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/0961203318815768","volume":"28","author":"EAA Christou","year":"2019","unstructured":"Christou EAA et al (2019) Sexual dimorphism in SLE: above and beyond sex hormones. Lupus 28(1):3\u201310. https:\/\/doi.org\/10.1177\/0961203318815768","journal-title":"Lupus"},{"issue":"9","key":"1321_CR18","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1136\/annrheumdis-2015-207923","volume":"75","author":"Z Cui","year":"2016","unstructured":"Cui Z et al (2016) Halofuginone attenuates osteoarthritis by inhibition of TGF-\u03b2 activity and H-type vessel formation in subchondral bone. Ann Rheum Dis 75(9):1714\u20131721. https:\/\/doi.org\/10.1136\/annrheumdis-2015-207923","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1321_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar2518","volume":"10","author":"M Daans","year":"2008","unstructured":"Daans M, Lories RJU, Luyten FP (2008) Dynamic activation of bone morphogenetic protein signaling in collagen-induced arthritis supports their role in joint homeostasis and disease. Arthritis Res Ther 10(5):1\u201310. https:\/\/doi.org\/10.1186\/ar2518","journal-title":"Arthritis Res Ther"},{"key":"1321_CR20","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/annrheumdis-2015-eular.4752","volume":"74","author":"RP Daly","year":"2015","unstructured":"Daly RP et al (2015) FRI0420 Health related quality of life in lupus differs by how patients perceive their health and how often they experience flares: findings from a cross-sectional online survey in the United States. Ann Rheum Dis 74:578\u2013579. https:\/\/doi.org\/10.1136\/annrheumdis-2015-eular.4752","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1321_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.transproceed.2007.01.031","volume":"39","author":"MJ Dami\u00e3o","year":"2007","unstructured":"Dami\u00e3o MJ et al (2007) The effects of rapamycin in the progression of renal fibrosis. Transplant Proc 39(2):457\u2013459. https:\/\/doi.org\/10.1016\/j.transproceed.2007.01.031","journal-title":"Transplant Proc"},{"issue":"October","key":"1321_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2019.104470","volume":"150","author":"R de la Puerta","year":"2019","unstructured":"de la Puerta R et al (2019) BMP-7 protects male and female rodents against neuropathic pain induced by nerve injury through a mechanism mediated by endogenous opioids. Pharmacol Res 150(October):1\u201311. https:\/\/doi.org\/10.1016\/j.phrs.2019.104470","journal-title":"Pharmacol Res"},{"issue":"1","key":"1321_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MNH.0000000000000087","volume":"24","author":"AE Decl\u00e8ves","year":"2015","unstructured":"Decl\u00e8ves AE, Sharma K (2015) Obesity and kidney disease: differential effects of obesity on adipose tissue and kidney inflammation and fibrosis. Curr Opin Nephrol Hypertens 24(1):28\u201336. https:\/\/doi.org\/10.1097\/MNH.0000000000000087","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"1321_CR24","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/ki.1997.162","volume":"51","author":"MA Dooley","year":"1997","unstructured":"Dooley MA et al (1997) Cyclophosphamide therapy for lupus nephritis: poor renal survival in black Americans. Kidney Int 51(4):1188\u20131195. https:\/\/doi.org\/10.1038\/ki.1997.162","journal-title":"Kidney Int"},{"issue":"1","key":"1321_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0961203316651741","volume":"26","author":"R Du Toit","year":"2017","unstructured":"Du Toit R et al (2017) Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus 26(1):38\u201347. https:\/\/doi.org\/10.1177\/0961203316651741","journal-title":"Lupus"},{"key":"1321_CR26","unstructured":"Eisner W (2014) Olympus halts OP-1 effort, RRY Publications. https:\/\/ryortho.com\/breaking\/olympus-halts-op-1-effort\/. Accessed 17 May 2023"},{"key":"1321_CR27","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-018-0728-2","author":"T Falasinnu","year":"2018","unstructured":"Falasinnu T et al (2018) The representation of gender and race\/ethnic groups in randomized clinical trials of individuals with systemic lupus erythematosus. Curr Rheumatol Rep. https:\/\/doi.org\/10.1007\/s11926-018-0728-2","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"1321_CR28","doi-asserted-by":"publisher","first-page":"S713","DOI":"10.1136\/annrheumdis-2020-216924","volume":"79","author":"A Fanouriakis","year":"2020","unstructured":"Fanouriakis A et al (2020) 2019 update of the joint European league against rheumatism and European renal association-European dialysis and transplant association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis 79(6):S713\u2013S723. https:\/\/doi.org\/10.1136\/annrheumdis-2020-216924","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"1321_CR29","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1002\/art.38720","volume":"66","author":"ED Ferucci","year":"2014","unstructured":"Ferucci ED et al (2014) Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska Native people, 2007\u20132009. Arthritis Rheumatol 66(9):2494\u20132502. https:\/\/doi.org\/10.1002\/art.38720","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1321_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/lupus-2022-000756","volume":"9","author":"JL Gamboa","year":"2022","unstructured":"Gamboa JL et al (2022) Intermuscular adipose tissue in patients with systemic lupus erythematosus. Lupus Sci Med 9(1):1\u20138. https:\/\/doi.org\/10.1136\/lupus-2022-000756","journal-title":"Lupus Sci Med"},{"issue":"30","key":"1321_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta11300","volume":"11","author":"K Garrison","year":"2007","unstructured":"Garrison K et al (2007) Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess 11(30):1\u20134","journal-title":"Health Technol Assess"},{"key":"1321_CR32","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/rheumatology\/keaa381","volume":"59","author":"M Gasparotto","year":"2020","unstructured":"Gasparotto M et al (2020) Lupus nephritis: Clinical presentations and outcomes in the 21st century. Rheumatology (United Kingdom) 59:39\u201351. https:\/\/doi.org\/10.1093\/rheumatology\/keaa381","journal-title":"Rheumatology (United Kingdom)"},{"issue":"14","key":"1321_CR33","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1177\/09612033221122983","volume":"31","author":"LA Gonz\u00e1lez","year":"2022","unstructured":"Gonz\u00e1lez LA et al (2022) Addressing health disparities as a function of ethnicity in systemic lupus erythematosus patients. Lupus 31(14):1691\u20131705. https:\/\/doi.org\/10.1177\/09612033221122983","journal-title":"Lupus"},{"issue":"8","key":"1321_CR34","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s10067-019-04511-7","volume":"38","author":"L Greenstein","year":"2019","unstructured":"Greenstein L, Makan K, Tikly M (2019) Burden of comorbidities in South Africans with systemic lupus erythematosus. Clin Rheumatol 38(8):2077\u20132082. https:\/\/doi.org\/10.1007\/s10067-019-04511-7","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1321_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2015","unstructured":"Hanly JG et al (2015) The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (United Kingdom) 55(2):252\u2013262. https:\/\/doi.org\/10.1093\/rheumatology\/kev311","journal-title":"Rheumatology (United Kingdom)"},{"issue":"2","key":"1321_CR36","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1681\/ASN.2017020217","volume":"29","author":"J Himmelfarb","year":"2018","unstructured":"Himmelfarb J et al (2018) Perioperative THR-184 and AKI after cardiac surgery. J Am Soc Nephrol 29(2):670\u2013679. https:\/\/doi.org\/10.1681\/ASN.2017020217","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1321_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/art.42375","volume":"75","author":"M Hocao\u01e7lu","year":"2023","unstructured":"Hocao\u01e7lu M et al (2023) Incidence, prevalence, and mortality of lupus nephritis: a population-based study over four decades using the lupus midwest network. Arthritis Rheumatol 75(4):567\u2013573. https:\/\/doi.org\/10.1002\/art.42375","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"1321_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/acr.20441.Tubulointerstitial","volume":"23","author":"C Hsieh","year":"2011","unstructured":"Hsieh C et al (2011) Tubulointerstitial inflammation and scarring predict outcome in lupus nephritis. Bone 23(1):1\u20137. https:\/\/doi.org\/10.1002\/acr.20441.Tubulointerstitial","journal-title":"Bone"},{"issue":"1","key":"1321_CR39","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/1471-2474-11-232","volume":"11","author":"DJ Hunter","year":"2010","unstructured":"Hunter DJ et al (2010) Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskel Disord 11(1):232. https:\/\/doi.org\/10.1186\/1471-2474-11-232","journal-title":"BMC Musculoskel Disord"},{"key":"1321_CR40","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1093\/rheumatology\/kep346","volume":"49","author":"D Isenberg","year":"2010","unstructured":"Isenberg D et al (2010) Original article Influence of race\/ethnicity on response to lupus nephritis treatment: the ALMS study. Rheumatology 49:128\u2013140. https:\/\/doi.org\/10.1093\/rheumatology\/kep346","journal-title":"Rheumatology"},{"issue":"8","key":"1321_CR41","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/j.autrev.2007.11.014","volume":"73","author":"A Jorge","year":"2021","unstructured":"Jorge A et al (2021) Hydroxychloroquine and mortality among patients with systemic lupus erythematosus in the general population. Arthritis Care Res 73(8):1219\u20131223. https:\/\/doi.org\/10.1016\/j.autrev.2007.11.014","journal-title":"Arthritis Care Res"},{"key":"1321_CR42","first-page":"53","volume":"29","author":"B Julian","year":"1999","unstructured":"Julian B et al (1999) Progress in the pathogenesis of IgA nephropathy. Adv Nephrol Necker Hosp 29:53\u201372","journal-title":"Adv Nephrol Necker Hosp"},{"issue":"6","key":"1321_CR43","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3899\/jrheum.111467","volume":"39","author":"K Ko","year":"2012","unstructured":"Ko K et al (2012) Genetic ancestry, serum interferon- \u03b1activity, and autoantibodies in systemic lupus erythematosus. J Rheumatol 39(6):1238\u20131240. https:\/\/doi.org\/10.3899\/jrheum.111467","journal-title":"J Rheumatol"},{"issue":"12","key":"1321_CR44","doi-asserted-by":"publisher","first-page":"3127","DOI":"10.1097\/01.ASN.0000095639.56212.BF","volume":"14","author":"KN Lai","year":"2003","unstructured":"Lai KN et al (2003) Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-\u03b2 synthesis and signal transduction in human mesangial cells via the renin-angiotensin system. J Am Soc Nephrol 14(12):3127\u20133137. https:\/\/doi.org\/10.1097\/01.ASN.0000095639.56212.BF","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1321_CR45","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10067-016-3476-6","volume":"36","author":"JS Lai","year":"2017","unstructured":"Lai JS et al (2017) An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL. Clin Rheumatol 36(3):555\u2013562. https:\/\/doi.org\/10.1007\/s10067-016-3476-6","journal-title":"Clin Rheumatol"},{"issue":"2","key":"1321_CR46","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/0961203316660625.Severe","volume":"26","author":"LB Lewandowski","year":"2017","unstructured":"Lewandowski LB et al (2017) Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa. Lupus 26(2):186\u2013194. https:\/\/doi.org\/10.1177\/0961203316660625.Severe","journal-title":"Lupus"},{"issue":"1","key":"1321_CR47","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/rheumatology\/kew399","volume":"56","author":"MJ Lewis","year":"2017","unstructured":"Lewis MJ, Jawad AS (2017) The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford, England) 56(1):67\u201377. https:\/\/doi.org\/10.1093\/rheumatology\/kew399","journal-title":"Rheumatology (Oxford, England)"},{"issue":"March","key":"1321_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2015.00114","volume":"6","author":"RX Li","year":"2015","unstructured":"Li RX, Tang SCW (2015) Role of bone morphogenetic protein-7 in renal fibrosis. Front Physiol 6(March):1\u20139. https:\/\/doi.org\/10.3389\/fphys.2015.00114","journal-title":"Front Physiol"},{"issue":"11","key":"1321_CR49","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s10067-019-04701-3","volume":"38","author":"Z Li","year":"2019","unstructured":"Li Z et al (2019) Altered body composition and increased visceral adipose tissue in premenopausal and late postmenopausal patients with SLE. Clin Rheumatol 38(11):3117\u20133127. https:\/\/doi.org\/10.1007\/s10067-019-04701-3","journal-title":"Clin Rheumatol"},{"issue":"11","key":"1321_CR50","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1093\/ndt\/gft247","volume":"28","author":"JA Lindquist","year":"2013","unstructured":"Lindquist JA, Mertens PR (2013) Myofibroblasts, regeneration or renal fibrosis-is there a decisive hint? Nephrol Dial Transpl 28(11):2678\u20132681. https:\/\/doi.org\/10.1093\/ndt\/gft247","journal-title":"Nephrol Dial Transpl"},{"issue":"11","key":"1321_CR51","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/art.40575","volume":"70","author":"A Londo\u00f1o Jimenez","year":"2018","unstructured":"Londo\u00f1o Jimenez A et al (2018) Brief report: tubulointerstitial damage in lupus nephritis: a comparison of the factors associated with tubulointerstitial inflammation and renal scarring. Arthritis Rheumatol 70(11):1801\u20131806. https:\/\/doi.org\/10.1002\/art.40575","journal-title":"Arthritis Rheumatol"},{"key":"1321_CR52","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.archoralbio.2016.03.004","volume":"67","author":"E Long","year":"2016","unstructured":"Long E et al (2016) The role of TGF-\u00df1 in osteoarthritis of the temporomandibular joint in two genetic mouse models. Arch Oral Biol 67:68\u201373. https:\/\/doi.org\/10.1016\/j.archoralbio.2016.03.004","journal-title":"Arch Oral Biol"},{"issue":"2","key":"1321_CR53","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/ard-2022-222839","volume":"82","author":"A Lorenzo-Vizcaya","year":"2022","unstructured":"Lorenzo-Vizcaya A, Isenberg DA (2022) Clinical trials in systemic lupus erythematosus: the dilemma\u2014why have phase III trials failed to confirm the promising results of phase II trials? Ann Rheum Dis 82(2):169\u2013174. https:\/\/doi.org\/10.1136\/ard-2022-222839","journal-title":"Ann Rheum Dis"},{"key":"1321_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a022327","volume":"10","author":"JW Lowery","year":"2018","unstructured":"Lowery JW, Rosen V (2018) Bone morphogenetic protein\u2013based therapeutic approaches. Cold Spring Harb Perspect Biol 10:1\u201328","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1321_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7290686","volume":"2016","author":"JW Lowery","year":"2016","unstructured":"Lowery JW, Brookshire B, Rosen V (2016) A survey of strategies to modulate the bone morphogenetic protein signaling pathway: current and future perspectives. Stem Cells Int 2016:1\u201315. https:\/\/doi.org\/10.1155\/2016\/7290686","journal-title":"Stem Cells Int"},{"issue":"23\u201324","key":"1321_CR56","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1101\/gad.307116.117","volume":"31","author":"X Lu","year":"2017","unstructured":"Lu X et al (2017) Opposing roles of TGF\u03b2 and BMP signaling in prostate cancer development. Genes Dev 31(23\u201324):2337\u20132342. https:\/\/doi.org\/10.1101\/gad.307116.117","journal-title":"Genes Dev"},{"key":"1321_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-8871-2_10","author":"CC Lu","year":"2019","unstructured":"Lu CC et al (2019) Role of podocyte injury in glomerulosclerosis. Adv Exp Med Biol. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_10","journal-title":"Adv Exp Med Biol"},{"key":"1321_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.colsurfb.2015.04.043","volume":"131","author":"Z Luo","year":"2015","unstructured":"Luo Z et al (2015) Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering. Colloids Surf B 131:73\u201382. https:\/\/doi.org\/10.1016\/j.colsurfb.2015.04.043","journal-title":"Colloids Surf B"},{"issue":"1\u20132","key":"1321_CR59","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2013.09.004","volume":"264","author":"K Mausner-Fainberg","year":"2013","unstructured":"Mausner-Fainberg K et al (2013) Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 264(1\u20132):91\u201399. https:\/\/doi.org\/10.1016\/j.jneuroim.2013.09.004","journal-title":"J Neuroimmunol"},{"issue":"6","key":"1321_CR60","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1245\/s10434-011-2024-5","volume":"19","author":"K Megumi","year":"2012","unstructured":"Megumi K et al (2012) Clinicopathological significance of BMP7 expression in esophageal squamous cell carcinoma. Ann Surg Oncol 19(6):2066\u20132071. https:\/\/doi.org\/10.1245\/s10434-011-2024-5","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"1321_CR61","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.2741\/3035","volume":"13","author":"G Mitu","year":"2008","unstructured":"Mitu G, Hirschberg R (2008) Bone morphogenetic protein-7 (BMP7) in chronic kidney disease. Front Biosci 13(12):4726\u20134739. https:\/\/doi.org\/10.2741\/3035","journal-title":"Front Biosci"},{"issue":"13","key":"1321_CR62","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1128\/mcb.20.13.4626-4634.2000","volume":"20","author":"DG Monroe","year":"2000","unstructured":"Monroe DG, Jin DF, Sanders MM (2000) Estrogen opposes the apoptotic effects of bone morphogenetic protein 7 on tissue remodeling. Mol Cell Biol 20(13):4626\u20134634. https:\/\/doi.org\/10.1128\/mcb.20.13.4626-4634.2000","journal-title":"Mol Cell Biol"},{"issue":"11","key":"1321_CR63","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1111\/j.1349-7006.2009.01301.x","volume":"100","author":"YR Na","year":"2009","unstructured":"Na YR et al (2009) Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. Cancer Sci 100(11):2218\u20132225. https:\/\/doi.org\/10.1111\/j.1349-7006.2009.01301.x","journal-title":"Cancer Sci"},{"issue":"1","key":"1321_CR64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s13402-011-0058-0","volume":"35","author":"HPH Naber","year":"2012","unstructured":"Naber HPH et al (2012) BMP-7 inhibits TGF-\u03b2-induced invasion of breast cancer cells through inhibition of integrin \u03b23 expression. Cell Oncol 35(1):19\u201328. https:\/\/doi.org\/10.1007\/s13402-011-0058-0","journal-title":"Cell Oncol"},{"key":"1321_CR65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2147\/IJNRD.S331484","volume":"14","author":"S Naicker","year":"2021","unstructured":"Naicker S et al (2021) Profiling biomarkers in HIV glomerular disease\u2014potential for the non-invasive diagnosis of HIVAN? Int J Nephrol Renovasc Dis 14:427\u2013440. https:\/\/doi.org\/10.2147\/IJNRD.S331484","journal-title":"Int J Nephrol Renovasc Dis"},{"issue":"280","key":"1321_CR66","first-page":"1","volume":"9","author":"CA Narasimhulu","year":"2020","unstructured":"Narasimhulu CA, Singla DK (2020) The role of bone morphogenetic protein 7 (BMP-7) in inflammation in heart diseases. Cells 9(280):1\u201330","journal-title":"Cells"},{"key":"1321_CR67","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.ebiom.2019.02.033","volume":"41","author":"J Ning","year":"2019","unstructured":"Ning J et al (2019) Opposing roles and potential antagonistic mechanism between TGF-\u03b2 and BMP pathways: implications for cancer progression. EBioMedicine 41:702\u2013710. https:\/\/doi.org\/10.1016\/j.ebiom.2019.02.033","journal-title":"EBioMedicine"},{"issue":"3","key":"1321_CR68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1152\/AJPRENAL.00371.2021","volume":"322","author":"JC Oates","year":"2022","unstructured":"Oates JC, Russell DL, Van Beusecum JP (2022) Endothelial cells: potential novel regulators of renal inflammation. Am J Physiol Renal Physiol 322(3):309\u2013321. https:\/\/doi.org\/10.1152\/AJPRENAL.00371.2021","journal-title":"Am J Physiol Renal Physiol"},{"issue":"12","key":"1321_CR69","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.7196\/SAMJ.2015.v105i12.10224","volume":"105","author":"IG Okpechi","year":"2015","unstructured":"Okpechi IG, Gcelu A, Ameh OI (2015) Lupus nephritis: An approach to diagnosis and treatment in South Africa. S Afr Med J 105(12):1071\u20131074. https:\/\/doi.org\/10.7196\/SAMJ.2015.v105i12.10224","journal-title":"S Afr Med J"},{"key":"1321_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/1524913","volume":"2022","author":"T Ollewagen","year":"2022","unstructured":"Ollewagen T et al (2022) Therapeutic benefit in rheumatoid cachexia illustrated using a novel primary human triple cell coculture model. Int J Inflamm 2022:1\u201314. https:\/\/doi.org\/10.1155\/2022\/1524913","journal-title":"Int J Inflamm"},{"issue":"2","key":"1321_CR71","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4415\/ANN","volume":"52","author":"E Ortona","year":"2016","unstructured":"Ortona E et al (2016) Sex-based differences in autoimmune diseases. Ann Ist Super Sanit\u00e0 52(2):205\u2013212. https:\/\/doi.org\/10.4415\/ANN","journal-title":"Ann Ist Super Sanit\u00e0"},{"issue":"December","key":"1321_CR72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.799788","volume":"12","author":"Q Pan","year":"2021","unstructured":"Pan Q et al (2021) Gut microbiota dysbiosis in systemic lupus erythematosus: novel insights into mechanisms and promising therapeutic strategies. Front Immunol 12(December):1\u201315. https:\/\/doi.org\/10.3389\/fimmu.2021.799788","journal-title":"Front Immunol"},{"issue":"September","key":"1321_CR73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmed.2021.654912","volume":"8","author":"FC Paquissi","year":"2021","unstructured":"Paquissi FC, Abensur H (2021) The Th17\/IL-17 axis and kidney diseases, with focus on lupus nephritis. Front Med 8(September):1\u201322. https:\/\/doi.org\/10.3389\/fmed.2021.654912","journal-title":"Front Med"},{"issue":"6","key":"1321_CR74","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1681\/ASN.2005111209","volume":"17","author":"I Peters","year":"2006","unstructured":"Peters I et al (2006) IGF-binding protein-3 modulates TGF-\u03b2\/BMP-signaling in glomerular podocytes. J Am Soc Nephrol 17(6):1644\u20131656. https:\/\/doi.org\/10.1681\/ASN.2005111209","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1321_CR75","doi-asserted-by":"publisher","first-page":"247","DOI":"10.14670\/HH-17.247","volume":"17","author":"AO Phillips","year":"2002","unstructured":"Phillips AO, Steadman R (2002) Diabetic nephropathy: the central role of renal proximal tubular cells in tubulointerstitial injury. Histol Histopathol 17(1):247\u2013252. https:\/\/doi.org\/10.14670\/HH-17.247","journal-title":"Histol Histopathol"},{"issue":"1","key":"1321_CR76","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/lupus-2016-000161","volume":"3","author":"L Plantinga","year":"2016","unstructured":"Plantinga L et al (2016) Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the georgians organized against lupus study. Lupus Sci Med 3(1):1\u20139. https:\/\/doi.org\/10.1136\/lupus-2016-000161","journal-title":"Lupus Sci Med"},{"issue":"1","key":"1321_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-020-00688-1","volume":"27","author":"L Pretorius","year":"2020","unstructured":"Pretorius L, Smith C (2020) The trace aminergic system: a gender-sensitive therapeutic target for IBS? J Biomed Sci 27(1):1\u201319. https:\/\/doi.org\/10.1186\/s12929-020-00688-1","journal-title":"J Biomed Sci"},{"issue":"2023","key":"1321_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.taap.2023.116399","volume":"461","author":"L Pretorius","year":"2023","unstructured":"Pretorius L, Smith C (2023) Tyramine-induced gastrointestinal dysregulation is attenuated via estradiol associated mechanisms in a zebrafish larval model. Toxicol Appl Pharmacol 461(2023):1\u201313. https:\/\/doi.org\/10.1016\/j.taap.2023.116399","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"1321_CR79","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s10787-021-00906-8","volume":"30","author":"L Pretorius","year":"2022","unstructured":"Pretorius L et al (2022) Alterations to microbial secretome by estrogen may contribute to sex bias in irritable bowel syndrome. Inflammopharmacology 30(1):267\u2013281. https:\/\/doi.org\/10.1007\/s10787-021-00906-8","journal-title":"Inflammopharmacology"},{"issue":"8","key":"1321_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pr7080476","volume":"7","author":"J Puetz","year":"2019","unstructured":"Puetz J, Wurm FM (2019) Recombinant proteins for industrial versus pharmaceutical purposes: a review of process and pricing. Processes 7(8):1\u20139. https:\/\/doi.org\/10.3390\/pr7080476","journal-title":"Processes"},{"issue":"2","key":"1321_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.retram.2021.103324","volume":"70","author":"A Ranjbar","year":"2022","unstructured":"Ranjbar A et al (2022) Allogeneic adipose-derived mesenchymal stromal cell transplantation for refractory lupus nephritis: results of a phase I clinical trial. Curr Res Transl Med 70(2):1\u201310. https:\/\/doi.org\/10.1016\/j.retram.2021.103324","journal-title":"Curr Res Transl Med"},{"issue":"11","key":"1321_CR82","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","volume":"56","author":"F Rees","year":"2017","unstructured":"Rees F et al (2017) The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (United Kingdom) 56(11):1945\u20131961. https:\/\/doi.org\/10.1093\/rheumatology\/kex260","journal-title":"Rheumatology (United Kingdom)"},{"issue":"May","key":"1321_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01104","volume":"10","author":"OP Rekvig","year":"2019","unstructured":"Rekvig OP (2019) The dsDNA, anti-dsDNA antibody, and lupus nephritis: What we agree on, what must be done, and what the best strategy forward could be. Front Immunol 10(May):1\u201317. https:\/\/doi.org\/10.3389\/fimmu.2019.01104","journal-title":"Front Immunol"},{"issue":"1","key":"1321_CR84","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3892\/ijo.23.1.89","volume":"23","author":"M Schwalbe","year":"2003","unstructured":"Schwalbe M et al (2003) Differential expression and regulation of bone morphogenetic protein 7 in breast cancer. Int J Oncol 23(1):89\u201395. https:\/\/doi.org\/10.3892\/ijo.23.1.89","journal-title":"Int J Oncol"},{"issue":"5","key":"1321_CR85","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.jaci.2020.09.038","volume":"147","author":"T Sconocchia","year":"2021","unstructured":"Sconocchia T et al (2021) Bone morphogenetic protein signaling regulates skin inflammation via modulating dendritic cell function. J Allergy Clin Immunol 147(5):1810\u20131822. https:\/\/doi.org\/10.1016\/j.jaci.2020.09.038","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"1321_CR86","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.3892\/ijo.2018.4469","volume":"53","author":"W Shen","year":"2018","unstructured":"Shen W et al (2018) Biological effects of BMP7 on small-cell lung cancer cells and its bone metastasis. Int J Oncol 53(3):1354\u20131362. https:\/\/doi.org\/10.3892\/ijo.2018.4469","journal-title":"Int J Oncol"},{"key":"1321_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.phrs.2022.106354","volume":"182","author":"H Shi","year":"2022","unstructured":"Shi H et al (2022) Perivascular adipose tissue in autoimmune rheumatic diseases. Pharmacol Res 182:1\u201327. https:\/\/doi.org\/10.1016\/j.phrs.2022.106354","journal-title":"Pharmacol Res"},{"issue":"1\u20132","key":"1321_CR88","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mce.2006.01.015","volume":"249","author":"T Shimizu","year":"2006","unstructured":"Shimizu T et al (2006) Involvement of the bone morphogenetic protein\/receptor system during follicle development in the bovine ovary: Hormonal regulation of the expression of bone morphogenetic protein 7 (BMP-7) and its receptors (ActRII and ALK-2). Mol Cell Endocrinol 249(1\u20132):78\u201383. https:\/\/doi.org\/10.1016\/j.mce.2006.01.015","journal-title":"Mol Cell Endocrinol"},{"issue":"7","key":"1321_CR89","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1139\/Y2012-102","volume":"90","author":"DK Singla","year":"2012","unstructured":"Singla DK et al (2012) Bone morphogenetic protein 7 polarizes THP-1 cells into M2 macrophages. Can J Physiol Pharmacol 90(7):947\u2013951. https:\/\/doi.org\/10.1139\/Y2012-102","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"1321_CR90","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1002\/art.38238.Population-Based","volume":"66","author":"E Somers","year":"2014","unstructured":"Somers E et al (2014) Population-based incidence and prevalence of systemic lupus erythematosus. Arthritis Rheumatol 66(2):369\u2013378. https:\/\/doi.org\/10.1002\/art.38238.Population-Based","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"1321_CR91","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.biopha.2006.09.001","volume":"60","author":"J St\u00f6ve","year":"2006","unstructured":"St\u00f6ve J et al (2006) Bone morphogenetic protein 7 (bmp-7) stimulates proteoglycan synthesis in human osteoarthritic chondrocytes in vitro. Biomed Pharmacother 60(10):639\u2013643. https:\/\/doi.org\/10.1016\/j.biopha.2006.09.001","journal-title":"Biomed Pharmacother"},{"key":"1321_CR92","unstructured":"Stryker completes sale of OP-1 for use in orthopaedic bone applications to Olympus (2011) Stryker. https:\/\/investors.stryker.com\/press-releases\/news-details\/2011\/Stryker-Completes-Sale-of-OP-1-for-use-in-Orthopaedic-Bone-Applications-to-Olympus\/default.aspx. Accessed 17 May 2023"},{"issue":"1","key":"1321_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10142-023-00994-5","volume":"23","author":"X Sun","year":"2023","unstructured":"Sun X et al (2023) Protective effect of bone morphogenetic protein-7 induced differentiation of bone marrow mesenchymal stem cells in rat with acute spinal cord injury. Funct Integr Genom 23(1):1\u201313. https:\/\/doi.org\/10.1007\/s10142-023-00994-5","journal-title":"Funct Integr Genom"},{"issue":"11","key":"1321_CR94","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/acr.22032","volume":"65","author":"B Sutanto","year":"2013","unstructured":"Sutanto B et al (2013) Experiences and perspectives of adults living with systemic lupus erythematosus: thematic synthesis of qualitative studies. Arthritis Care Res 65(11):1752\u20131765. https:\/\/doi.org\/10.1002\/acr.22032","journal-title":"Arthritis Care Res"},{"issue":"3","key":"1321_CR95","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1191\/096120301671376017","volume":"10","author":"K Takada","year":"2001","unstructured":"Takada K, Illei GG, Boumpas DT (2001) Cyclophosphamide for the treatment of systemic lupus erythematosus. Lupus 10(3):154\u2013161. https:\/\/doi.org\/10.1191\/096120301671376017","journal-title":"Lupus"},{"issue":"3","key":"1321_CR96","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1677\/JOE-08-0226","volume":"199","author":"M Takahasi","year":"2008","unstructured":"Takahasi M et al (2008) Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. J Endocrinol 199(3):445\u2013455. https:\/\/doi.org\/10.1677\/JOE-08-0226","journal-title":"J Endocrinol"},{"issue":"319","key":"1321_CR97","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-020-2547-4","volume":"11","author":"Y Tian","year":"2020","unstructured":"Tian Y et al (2020) Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress. Cell Death Dis 11(319):1\u201319. https:\/\/doi.org\/10.1038\/s41419-020-2547-4","journal-title":"Cell Death Dis"},{"issue":"5","key":"1321_CR98","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1096\/fj.11-199067","volume":"26","author":"KL Townsend","year":"2012","unstructured":"Townsend KL et al (2012) Bone morphogenetic protein 7 (BMP7) reverses obesity and regulates appetite through a central mTOR pathway. FASEB J 26(5):2187\u20132196. https:\/\/doi.org\/10.1096\/fj.11-199067","journal-title":"FASEB J"},{"issue":"May","key":"1321_CR99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fbioe.2022.884601","volume":"10","author":"KL Townsend","year":"2022","unstructured":"Townsend KL et al (2022) Silk hydrogel-mediated delivery of bone morphogenetic protein 7 directly to subcutaneous white adipose tissue increases browning and energy expenditure. Front Bioeng Biotechnol 10(May):1\u201311. https:\/\/doi.org\/10.3389\/fbioe.2022.884601","journal-title":"Front Bioeng Biotechnol"},{"issue":"12","key":"1321_CR100","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos GC et al (2016) New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol 12(12):716\u2013730. https:\/\/doi.org\/10.1038\/nrrheum.2016.186","journal-title":"Nat Rev Rheumatol"},{"issue":"3","key":"1321_CR101","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.spinee.2007.03.012","volume":"8","author":"AR Vaccaro","year":"2008","unstructured":"Vaccaro AR et al (2008) The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study. Spine J 8(3):457\u2013465. https:\/\/doi.org\/10.1016\/j.spinee.2007.03.012","journal-title":"Spine J"},{"issue":"13","key":"1321_CR102","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1039\/d1cs00659b","volume":"51","author":"M Vallet-Reg\u00ed","year":"2022","unstructured":"Vallet-Reg\u00ed M et al (2022) Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? Chem Soc Rev 51(13):5365\u20135451. https:\/\/doi.org\/10.1039\/d1cs00659b","journal-title":"Chem Soc Rev"},{"issue":"9","key":"1321_CR103","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","volume":"13","author":"M Versini","year":"2014","unstructured":"Versini M et al (2014) Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev 13(9):981\u20131000. https:\/\/doi.org\/10.1016\/j.autrev.2014.07.001","journal-title":"Autoimmun Rev"},{"issue":"9","key":"1321_CR104","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1093\/rheumatology\/kem180","volume":"46","author":"S Wadee","year":"2007","unstructured":"Wadee S, Tikly M, Hopley M (2007) Causes and predictors of death in South Africans with systemic lupus erythematosus. Rheumatology 46(9):1487\u20131491. https:\/\/doi.org\/10.1093\/rheumatology\/kem180","journal-title":"Rheumatology"},{"issue":"April","key":"1321_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biocel.2019.105613","volume":"116","author":"Y Xiao","year":"2019","unstructured":"Xiao Y et al (2019) BMP-7\/Smads-induced inhibitor of differentiation 2 (Id2) upregulation and Id2\/Twist interaction was involved in attenuating diabetic renal tubulointerstitial fibrosis. Int J Biochem Cell Biol 116(April):1\u20139. https:\/\/doi.org\/10.1016\/j.biocel.2019.105613","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"1321_CR106","doi-asserted-by":"publisher","first-page":"65","DOI":"10.22088\/cjim.10.1.65","volume":"10","author":"Y Yuliasih","year":"2019","unstructured":"Yuliasih Y, Rahmawati LD, Putri RM (2019) Th17\/Treg ratio and disease activity in systemic lupus erythematosus. Casp J Intern Med 10(1):65\u201372. https:\/\/doi.org\/10.22088\/cjim.10.1.65","journal-title":"Casp J Intern Med"},{"issue":"6 54-6","key":"1321_CR107","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1152\/ajprenal.00191.2002","volume":"285","author":"M Zeisberg","year":"2003","unstructured":"Zeisberg M et al (2003) Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models. Am J Physiol Renal Physiol 285(6 54-6):1060\u20131067. https:\/\/doi.org\/10.1152\/ajprenal.00191.2002","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"1321_CR108","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1007\/s10875-012-9724-x","volume":"32","author":"Y Zhang","year":"2012","unstructured":"Zhang Y et al (2012) The lupus-derived anti-double-stranded DNA IgG contributes to myofibroblast-like phenotype in mesangial cells. J Clin Immunol 32(6):1270\u20131278. https:\/\/doi.org\/10.1007\/s10875-012-9724-x","journal-title":"J Clin Immunol"},{"issue":"6","key":"1321_CR109","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3892\/br.2013.164","volume":"1","author":"R Zhang","year":"2013","unstructured":"Zhang R et al (2013) Bone morphogenetic protein 7 upregulates the expression of nestin and glial fibrillary acidic protein in rats with cerebral ischemia-reperfusion injury. Biomed Rep 1(6):895\u2013900. https:\/\/doi.org\/10.3892\/br.2013.164","journal-title":"Biomed Rep"},{"issue":"1","key":"1321_CR110","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12967-016-0911-z","volume":"14","author":"H Zhang","year":"2016","unstructured":"Zhang H et al (2016) Anti-dsDNA antibodies bind to TLR4 and activate NLRP3 inflammasome in lupus monocytes\/macrophages. J Transl Med 14(1):1\u201312. https:\/\/doi.org\/10.1186\/s12967-016-0911-z","journal-title":"J Transl Med"},{"issue":"6","key":"1321_CR111","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3881\/j.issn.1000-503X.2014.06.018.Effect","volume":"36","author":"L Zheng","year":"2014","unstructured":"Zheng L et al (2014) Effect of bone morphogenetic protein 7 on differentiation of adipose derived mesenchymal stem cells into brown adipocytes in rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 36(6):654\u2013659. https:\/\/doi.org\/10.3881\/j.issn.1000-503X.2014.06.018.Effect","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"10","key":"1321_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cells9102236","volume":"9","author":"N Ziller","year":"2020","unstructured":"Ziller N et al (2020) Sex differences in diabetes- and TGF-\u03b21-induced renal damage. Cells 9(10):1\u201326. https:\/\/doi.org\/10.3390\/cells9102236","journal-title":"Cells"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01321-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01321-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01321-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T21:15:48Z","timestamp":1695590148000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01321-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,25]]},"references-count":112,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1321"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01321-x","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,25]]},"assertion":[{"value":"3 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}